Dr. Reddy’s seeks DCGI nod for Sputnik-V phase-3 trials
Published
Pharma major Dr. Reddy’s Laboratories on Monday said safety data pertaining to phase-2 clinical trial of Russia’s Sputnik-V COVID-19 vaccine candidate
Full ArticlePublished
Pharma major Dr. Reddy’s Laboratories on Monday said safety data pertaining to phase-2 clinical trial of Russia’s Sputnik-V COVID-19 vaccine candidate
Full ArticleDr Reddy’s to conduct trial on 1,500 subjects
The Drugs Controller General of India (DCGI) has approved conducting phase III trials of the country's first DNA vaccine candidate..